MedNews: MediLink Therapeutics enters into a multi-target technology platform license with the immunotherapy company BioNTech (Nasdaq: BNTX) for therapies for cancer and other serious diseases
Strategists and Implementers
for growing companies globally
Recent Postings
MedNews: Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for breakthroughs in diagnostics innovation, engineering and manufacturing
MedNews: Lilly increases its manufacturing investment in its newest Indiana site to $9 Billion to boost API production for Tirzepatide for weight loss and diabetes and its pipeline medicines
MedNews: South Korea based HoneyNaps secures $11.6 million to advance its FDA approved AI sleep diagnosis software
MedNews: Clinical-stage pharmaceutical company Inhibikase Therapeutics (Nasdaq: IKT) raises $4 million
MedNews: Progentos Therapeutics raises $65 million for treatments for multiple sclerosis and other degenerative diseases
MedNews: The cancer and life-threatening infectious diseases medical therapeutic company Aethlon Medical (Nasdaq: AEMD) raises $4.7 million
MedNews: Backpack Healthcare closes $14 million funding to revolutionize pediatric mental health care
MedNews: Medical device company R3 Vascular announces $87 million financing
MedNews: Averto Medical debuts with $30 million financing to advance medical device that avoids the need for ostomy
MedNews: Context Therapeutics (Nasdaq CNTX) raises $100 million in a private placement
Vitestro raises €20 million for its autonomous blood draw device
MedNews: FDA Grants Full Approval for Pfizer's and Genmab's TIVDAK to Treat Recurrent or Metastatic Cervical Cancer
MedNews: Treatment provider for severe mental illness, Amae Health, raises $15 million